206 related articles for article (PubMed ID: 29933627)
1. New Chromane-Based Derivatives as Inhibitors of
Pini E; Poli G; Tuccinardi T; Chiarelli LR; Mori M; Gelain A; Costantino L; Villa S; Meneghetti F; Barlocco D
Molecules; 2018 Jun; 23(7):. PubMed ID: 29933627
[TBL] [Abstract][Full Text] [Related]
2. Inhibition studies of Mycobacterium tuberculosis salicylate synthase (MbtI).
Manos-Turvey A; Bulloch EM; Rutledge PJ; Baker EN; Lott JS; Payne RJ
ChemMedChem; 2010 Jul; 5(7):1067-79. PubMed ID: 20512795
[TBL] [Abstract][Full Text] [Related]
3. Structure and mechanism of MbtI, the salicylate synthase from Mycobacterium tuberculosis.
Zwahlen J; Kolappan S; Zhou R; Kisker C; Tonge PJ
Biochemistry; 2007 Jan; 46(4):954-64. PubMed ID: 17240979
[TBL] [Abstract][Full Text] [Related]
4. Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.
Chiarelli LR; Mori M; Barlocco D; Beretta G; Gelain A; Pini E; Porcino M; Mori G; Stelitano G; Costantino L; Lapillo M; Bonanni D; Poli G; Tuccinardi T; Villa S; Meneghetti F
Eur J Med Chem; 2018 Jul; 155():754-763. PubMed ID: 29940465
[TBL] [Abstract][Full Text] [Related]
5. Integration of ligand and structure based approaches for identification of novel MbtI inhibitors in Mycobacterium tuberculosis and molecular dynamics simulation studies.
Maganti L; Grandhi P; Ghoshal N
J Mol Graph Model; 2016 Nov; 70():14-22. PubMed ID: 27639087
[TBL] [Abstract][Full Text] [Related]
6. New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents.
Chiarelli LR; Mori M; Beretta G; Gelain A; Pini E; Sammartino JC; Stelitano G; Barlocco D; Costantino L; Lapillo M; Poli G; Caligiuri I; Rizzolio F; Bellinzoni M; Tuccinardi T; Villa S; Meneghetti F
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):823-828. PubMed ID: 30889995
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening.
Vasan M; Neres J; Williams J; Wilson DJ; Teitelbaum AM; Remmel RP; Aldrich CC
ChemMedChem; 2010 Dec; 5(12):2079-87. PubMed ID: 21053346
[TBL] [Abstract][Full Text] [Related]
8. Implications of binding mode and active site flexibility for inhibitor potency against the salicylate synthase from Mycobacterium tuberculosis.
Chi G; Manos-Turvey A; O'Connor PD; Johnston JM; Evans GL; Baker EN; Payne RJ; Lott JS; Bulloch EM
Biochemistry; 2012 Jun; 51(24):4868-79. PubMed ID: 22607697
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of M. tuberculosis salicylate synthase (MbtI) inhibitors designed to probe plasticity in the active site.
Manos-Turvey A; Cergol KM; Salam NK; Bulloch EM; Chi G; Pang A; Britton WJ; West NP; Baker EN; Lott JS; Payne RJ
Org Biomol Chem; 2012 Dec; 10(46):9223-36. PubMed ID: 23108268
[TBL] [Abstract][Full Text] [Related]
10. The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin, reveals it to be a salicylate synthase.
Harrison AJ; Yu M; Gårdenborg T; Middleditch M; Ramsay RJ; Baker EN; Lott JS
J Bacteriol; 2006 Sep; 188(17):6081-91. PubMed ID: 16923875
[TBL] [Abstract][Full Text] [Related]
11. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
[TBL] [Abstract][Full Text] [Related]
12. Stereocontrolled Synthesis of a Potential Transition-State Inhibitor of the Salicylate Synthase MbtI from Mycobacterium tuberculosis.
Liu Z; Liu F; Aldrich CC
J Org Chem; 2015 Jul; 80(13):6545-52. PubMed ID: 26035083
[TBL] [Abstract][Full Text] [Related]
13. Shedding X-ray Light on the Role of Magnesium in the Activity of
Mori M; Stelitano G; Gelain A; Pini E; Chiarelli LR; Sammartino JC; Poli G; Tuccinardi T; Beretta G; Porta A; Bellinzoni M; Villa S; Meneghetti F
J Med Chem; 2020 Jul; 63(13):7066-7080. PubMed ID: 32530281
[TBL] [Abstract][Full Text] [Related]
14. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
[TBL] [Abstract][Full Text] [Related]
15. Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.
Goins CM; Dajnowicz S; Thanna S; Sucheck SJ; Parks JM; Ronning DR
ACS Infect Dis; 2017 May; 3(5):378-387. PubMed ID: 28285521
[TBL] [Abstract][Full Text] [Related]
16. Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis.
Minovski N; Perdih A; Novic M; Solmajer T
J Comput Chem; 2013 Apr; 34(9):790-801. PubMed ID: 23280926
[TBL] [Abstract][Full Text] [Related]
17. Iron Acquisition Pathways as Targets for Antitubercular Drugs.
Meneghetti F; Villa S; Gelain A; Barlocco D; Chiarelli LR; Pasca MR; Costantino L
Curr Med Chem; 2016; 23(35):4009-4026. PubMed ID: 27281295
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity.
Soni V; Suryadevara P; Sriram D; ; Kumar S; Nandicoori VK; Yogeeswari P
J Mol Model; 2015 Jul; 21(7):174. PubMed ID: 26078037
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of C-5 modified 2'-deoxyuridine monophosphates as inhibitors of M. tuberculosis thymidylate synthase.
Alexandrova LA; Chekhov VO; Shmalenyuk ER; Kochetkov SN; El-Asrar RA; Herdewijn P
Bioorg Med Chem; 2015 Nov; 23(22):7131-7. PubMed ID: 26482569
[TBL] [Abstract][Full Text] [Related]
20. Glutamate Racemase Is the Primary Target of β-Chloro-d-Alanine in Mycobacterium tuberculosis.
Prosser GA; Rodenburg A; Khoury H; de Chiara C; Howell S; Snijders AP; de Carvalho LP
Antimicrob Agents Chemother; 2016 Oct; 60(10):6091-9. PubMed ID: 27480853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
